DISCONTINUED OPERATIONS (Tables)

3 Months Ended

Mar. 31, 2023

Discontinued Operations and Disposal Groups [Abstract]

SCHEDULE OF COMPONENTS OF ASSETS AND LIABILITIES AND REVENUE CLASSIFIED AS DISCONTINUED OPERATIONS

The table below presents the significant components of its former Pharma Solutions business unit’s results included within loss from discontinued operations, net of tax in the condensed consolidated statements of operations for the three- months ended March 31, 2023 and 2022.

	For The Three Months Ended
	March 31,
	2023			2022
Revenue, net	$	-		$	2,454
Loss from discontinued operations		-			(1,058	)
Income tax expense		79			54
Loss from discontinued operations, net of tax	$	(79	)	$	(1,112	)

Cash used from discontinued operations, operating activities, for the three months ended March 31, 2022 was approximately $1.1 million. There was no cash flow activity from discontinued operations for the three months ended March 31, 2023. Depreciation and amortization expense within discontinued operations for the three months ended March 31, 2022 was $0.4 million. There was no depreciation and amortization expense for the three months ended March 31, 2023.